Quality of prospective controlled randomized trials regarding platelet-rich plasma injection for osteoarthritis of the knee
- 10 January 2021
- journal article
- research article
- Published by Elsevier in Journal of Orthopaedic Science
- Vol. 27 (1) , 190-198
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The Anti-inflammatory and Matrix Restorative Mechanisms of Platelet-Rich Plasma in OsteoarthritisThe American Journal of Sports Medicine, 2013
- Comparison of Intra‐Articular Injections of Plasma Rich in Growth Factors (PRGF‐Endoret) Versus Durolane Hyaluronic Acid in the Treatment of Patients With Symptomatic Osteoarthritis: A Randomized Controlled TrialArthroscopy, 2013
- Treatment With Platelet-Rich Plasma Is More Effective Than Placebo for Knee OsteoarthritisThe American Journal of Sports Medicine, 2013
- Comparison Between Hyaluronic Acid and Platelet-Rich Plasma, Intra-articular Infiltration in the Treatment of GonarthrosisThe American Journal of Sports Medicine, 2012
- Knee replacementThe Lancet, 2012
- Platelet‐Rich Plasma: A Milieu of Bioactive FactorsArthroscopy, 2012
- Reported Outcomes in Major Cardiovascular Clinical Trials Funded by For-Profit and Not-for-Profit Organizations: 2000-2005JAMA, 2006
- Evidence-based orthopaedic surgeryThe Journal of Bone and Joint Surgery. British volume, 2005
- Association of Funding and Conclusions in Randomized Drug TrialsJAMA, 2003
- Studies of surgical outcome after patellar tendinopathy: clinical significance of methodological deficiencies and guidelines for future studiesScandinavian Journal of Medicine & Science in Sports, 2000